Sulforaphane induces inhibition of human umbilical vein endothelial cells proliferation by apoptosis

被引：55

作者：

Asakage M. ^{[1
]}

Tsuno N.H. ^{[1
,2
]}

Kitayama J. ^{[1
]}

Tsuchiya T. ^{[1
]}

Yoneyama S. ^{[1
]}

Yamada J. ^{[1
]}

Okaji Y. ^{[2
]}

Kaisaki S. ^{[1
]}

Osada T. ^{[1
]}

Takahashi K. ^{[2
]}

Nagawa H. ^{[1
]}

机构：

[1] Department of Surgical Oncology, University of Tokyo, Bunkyo-ku, Tokyo 113-0033

[2] Faculty of Medicine, Department of Transfusion Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033

来源：

Angiogenesis | 2006年 / 9卷 / 2期

关键词：

Angiogenesis inhibitors; Apoptosis; Cell proliferation; Endothelial cells; Sulforaphane;

D O I：

10.1007/s10456-006-9034-0

中图分类号：

学科分类号：

摘要：

Sulforaphane (SUL), one of the isothiocyanates (ITCs), has recently been focused due to its inhibitory effects on tumor cell growth in vitro and in vivo, which is dependent on the direct effect on cancer cells. In the present study, we aimed to investigate the potential anti-angiogenic effect of SUL and its mechanism of action. Using the human umbilical vein endothelial cells (HUVECs) as a model of angiogenesis, we investigated the effect of SUL on the various steps of angiogenesis, including the proliferation of endothelial cells, tubular formation, and matrix metalloproteinase (MMP) production. Sulforaphane induced a dose-dependent decrease in the proliferative activity of endothelial cells, which was dependent on cell apoptosis. Also SUL inhibited tube formation on matrigel, but did not affect MMP production. The present results demonstrate the anti-angiogenic activity of SUL and its potential use as an anti-cancer drug is suggested. © Springer Science+Business Media B.V. 2006.

引用

页码：83 / 91

页数：8

共 35 条

[1]

Kohlmeier L., Mendez M., Controversies surrounding diet and breast cancer, Proc Nutr Soc, 56, pp. 369-382, (1997)

[2]

Zhang S.M., Hunter D.J., Rosner B.A., Et al., Intakes of fruits, vegetables, and related nutrients and the risk of non-Hodgkin's lymphoma among women, Cancer Epidemiol Biomarkers Prev, 9, pp. 477-485, (2000)

[3]

Cohen J.H., Kristal A.R., Stanford J.L., Fruit and vegetable intakes and prostate cancer risk, J Natl Cancer Inst, 92, pp. 61-68, (2000)

[4]

Kolonel L.N., Hankin J.H., Whittemore A.S., Et al., Vegetables, fruits, legumes and prostate cancer: A multiethnic case-control study, Cancer Epidemiol Biomarkers Prev, 9, pp. 795-804, (2000)

[5]

Hecht S.S., Inhibition of carcinogenesis by isothiocyanates, Drug Metab Rev, 32, pp. 395-411, (2000)

[6]

Wattenberg L.W., Inhibitory effects of benzyl isothiocyanate administered shortly before diethylnitrosamine or benzo[a]pyrene on pulmonary and forestomach neoplasia in A/J mice, Carcinogenesis, 8, pp. 1971-1973, (1987)

[7]

Yang Y.M., Conaway C.C., Chiao J.W., Et al., Inhibition of benzo(a)pyrene-induced lung tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the postinitiation phase is associated with activation of mitogen-activated protein kinases and p53 activity and induction of apoptosis, Cancer Res, 62, pp. 2-7, (2002)

[8]

Zhang Y., Kensler T.W., Cho C.G., Et al., Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates, Proc Natl Acad Sci USA, 91, pp. 3147-3150, (1994)

[9]

Zhang Y., Talalay P., Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes, Cancer Res, 58, pp. 4632-4639, (1998)

[10]

Prestera T., Talalay P., Electrophile and antioxidant regulation of enzymes that detoxify carcinogens, Proc Natl Acad Sci USA, 92, pp. 8965-8969, (1995)

← 1 2 3 4 →